Crown Castle Inc. (NYSE: CCI): When MoffettNathanson downgraded the shares to Outperform Weight from Market Perform, it trimmed its $161 target price to $155. The consensus target is $157.78. Thursday’s close was at $132.55.
DiamondRock Hospitality Co. (NYSE: DRH): Though Wells Fargo upgraded the shares to Overweight from Equal Weight, it also trimmed its $10.50 target price to $9. The consensus target is $10.18, and the stock closed at $7.80 on Thursday.
DraftKings Inc. (NASDAQ: DKNG): Oppenheimer reiterated an Outperform rating with a $28 target price. The consensus target is $24.14. Thursday’s close was at $18.91.
Enphase Energy Inc. (NASDAQ: ENPH): Goldman Sachs lowered its $329 target price on the Buy-rated shares to $295, the same as the consensus target. The stock closed on Thursday at $205.27.
Fluence Energy Inc. (NASDAQ: FLNC): Goldman Sachs upgraded the shares to Buy from Neutral. It also bumped its $25 target price up to $29, above the $26 consensus target. Thursday’s $18.64 close was up almost 15% for the day on the upgrade and positive corporate news.
GitLab Inc. (NASDAQ: GTLB): SMBC Nikko initiated coverage with a Neutral rating and a $37 price target. The consensus target is $50.38, and Thursday’s closing print was $33.01.
Global Payments Inc. (NYSE: GPN): Barclays resumed coverage with an Overweight rating and a $125 target. The consensus target is $142.04. The stock closed on Thursday at $103.14.
Globus Medical Inc. (NYSE: GMED): Canaccord Genuity’s upgrade was from Hold to Buy with a $67 target price. The consensus target is $67.17. Thursday’s close at $55.71 was up over 4% on the day.
Holley Inc. (NYSE: HLLY): Canaccord Genuity started coverage with a Buy rating and a $5 target price. The consensus target is $3.91. The stock closed almost 13% higher on Thursday at $2.64 after the upgrade.
Interpublic Group of Companies Inc. (NYSE: IPG): BofA Securities lifted its Neutral rating to Buy, and its $38 target price is now $40. The consensus target is $40.50. The stock closed on Thursday at $36.46.
Juniper Networks Inc. (NYSE: JNPR) Evercore ISI upgraded the stock to Outperform from In Line and lifted the $34 target price to $38. The consensus target is $36.07. The shares closed on Thursday at $34.04.
Neurocrine Biosciences Inc. (NASDAQ: NBIX): Canaccord Genuity upgraded the shares to Buy from Hold. The target price increased from $124 to $132, above the $126.62 consensus target. Thursday’s closing print was $99.21.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
